Qi Fang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Epithelial Mesenchymal Transition

Endoplasmic Reticulum Stress

Ischemia Reperfusion Injury

Top Venues

Analytical chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Qi Fang, Quanyi Liu, Zhimin Song, Xiaojun Zhang, Shaojun Dong
A NAD(P)H oxidase mimic for catalytic tumor therapy via a deacetylase SIRT7-mediated AKT/GSK3β pathway. Nanoscale (2024)
Qi Fang, Quanyi Liu, Zhimin Song, Xiaojun Zhang, Shaojun Dong
A NAD(P)H oxidase mimic for catalytic tumor therapy via a deacetylase SIRT7-mediated AKT/GSK3β pathway. Nanoscale 16 (13) (2024)
Qi Fang, Quanyi Liu, Zhimin Song, Yu Wang, Xiaojun Zhang, Jun Cao, Jian Sun, Chong-Bo Ma, Shaojun Dong
Innovative Colorimetric NQO1 Detection Strategy via Substrate Competitive and Biomimetic Cascade Reactions with a Highly Active NADH Oxidase Mimic. Analytical chemistry 96 (32) (2024)
Qi Fang, Quanyi Liu, Zhimin Song, Yu Wang, Xiaojun Zhang, Jun Cao, Jian Sun, Chong-Bo Ma, Shaojun Dong
Innovative Colorimetric NQO1 Detection Strategy via Substrate Competitive and Biomimetic Cascade Reactions with a Highly Active NADH Oxidase Mimic. Analytical chemistry (2024)
Qi Fang, Quanyi Liu, Zhimin Song, Xiaojun Zhang, Shaojun Dong
A NAD(P)H oxidase mimic for catalytic tumor therapy via a deacetylase SIRT7-mediated AKT/GSK3β pathway. Nanoscale 16 (13) (2024)
Qi Fang, Quanyi Liu, Zhimin Song, Xiaojun Zhang, Shaojun Dong
A NAD(P)H oxidase mimic for catalytic tumor therapy via a deacetylase SIRT7-mediated AKT/GSK3β pathway. Nanoscale 16 (13) (2024)